Amsino International

What Amsino International does

Amsino International is a privately-held medical device manufacturer founded in 1993 and headquartered in Pomona, California. The company produces a diversified portfolio of single-use medical devices organized under multiple brand families: AMSure (enteral feeding systems, respiratory therapy systems, surgical and nursing solutions, urological care, and 2025-launched Foley catheter trays), AMSafe (IV medication delivery systems including AMSafe-3 and MicroClave brands), RECEPTAL (suction and fluid management), and MedXL (an acquired brand). Core technology consists of vertically integrated single-use device manufacturing, with production capacity exceeding 500 million units annually following the November 2024 acquisition of MedXL Inc. and Liebel-Flarsheim Canada Inc., which added Quebec-based manufacturing facilities and North American supply chain resilience.

The company generates revenue primarily through hardware sales of these consumable medical devices to hospitals, health systems, and home healthcare providers. Go-to-market is anchored on distribution through group purchasing organizations (GPOs) and direct enterprise supply agreements. Amsino has secured multi-year GPO partnerships with Partners Cooperative (three-year deal effective January 2026) and ampiezza, a Vizient Aggregation Group covering over 90 health systems, alongside an exclusive flush syringe supply agreement with Mount Sinai Health System. Pricing is not publicly disclosed; transactions occur under contracted GPO pricing with tiered volume commitments, supported by the Supply Resiliency Program that dedicates a defined share of North American capacity to specific partners.

Ownership is private, with a substantial equity investment from private equity firm Novo Tellus in June 2024 earmarked for global production, R&D, and supply chain expansion in the US and Asia. Operations span North America and Asia, with manufacturing in California and Quebec and a multilingual website (English, Spanish, Chinese) supporting international distribution. The company is led by Richard Lee as Owner, Chairman, President, and CEO, and reports contact channels at its Pomona headquarters.

Name

Amsino International

Legal name

Amsino International, Inc.

Website

https://amsinocatalog.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

Amsino International is a privately-held medical device manufacturer founded in 1993 that produces single-use medical consumables — including prefilled syringes, enteral feeding, respiratory therapy, urological care, and waste fluid management products — for hospitals, health systems, and home healthcare providers across North America and Asia.

Ownership category

akta.pro rank

Product category

Single-Use Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Medical Supplies & Consumables Wholesale (Non-Device) (CRAOAHAE)

Keywords

• Single-use medical devices
• IV therapy products
• Urological care supplies
• Enteral feeding systems
• Respiratory therapy products

Headquarters

HQ city

Pomona

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Device Manufacturing and Sales: Amsino generates revenue through the manufacture and sale of single-use medical devices including pre-filled syringes, catheters, enteral feeding systems, respiratory therapy products, and urological care products to healthcare providers, hospitals, and health systems.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Amsino International is a medical device manufacturer that designs, produces, and sells single-use medical consumables including pre-filled flush syringes, sterile water and saline, IV medication delivery systems (AMSafe/AMSafe-3/MicroClave), enteral feeding systems, respiratory therapy systems, surgical and nursing solutions, urological care products (including Foley catheter trays), and RECEPTAL suction and fluid waste management systems. The company sells these products to hospitals, health systems, and home healthcare providers primarily through GPO contracts and direct enterprise supply agreements.

Product overview

Amsino International is a global manufacturer of single-use medical devices offering a diversified portfolio of medical consumable products organized under multiple brand families. The core product lines include Prefilled Syringes and Sterile Water/Saline for irrigation; AMSafe (including AMSafe-3 and MicroClave) for IV medication delivery; AMSure-branded systems for enteral feeding, respiratory therapy, surgical/nursing care, and urological care; and RECEPTAL for waste fluid management. The company also acquired MedXL in November 2024 to expand manufacturing capacity. Products are distributed through healthcare GPO partnerships and direct supply agreements with health systems, with manufacturing facilities capable of producing over 500 million units annually.

Differentiator

Problem solved

Functional benefit

Brands

• AMSure: Product line for enteral feeding systems, respiratory therapy systems, surgical and nursing solutions, and urological care
• AMSafe
• RECEPTAL
• MedXL
• AMSure Foley Catheter Trays

Products and services

• Prefilled Syringes Pre-filled flush syringes for medical irrigation and medication delivery, available in multiple configurations for healthcare providers across hospitals and health systems.
• Sterile Water and Saline Sterile water and saline solutions for medical irrigation, wound care, and general healthcare applications in clinical and procedural settings.
• AMSafe Medication Delivery Systems IV infusion and medication delivery products offered under the AMSafe, AMSafe-3, and MicroClave brands for safe intravenous therapy in hospitals and health systems.
• AMSure Enteral Feeding Systems Complete line of enteral feeding syringes, feeding sets, feeding pumps, and irrigation trays for patient nutrition delivery in hospital and home care settings.
• AMSure Respiratory Therapy Systems Respiratory care products designed for patients, families, residents, and healthcare customers requiring breathing support.
• AMSure Surgical and Nursing Solutions Ancillary surgical and nursing products necessary for comprehensive patient care in clinical and procedural settings.
• AMSure Urological Care Complete urology product portfolio, including Foley catheters and trays, designed to help reduce urinary tract infections (UTIs) in inpatient and home care settings.
• AMSure Foley Catheter Trays Pre-assembled Foley catheter trays for urological care applications, launched in 2025 as part of the AMSure Urological Care portfolio.
• RECEPTAL Suction and Fluid Management Suction and fluid management systems that help hospitals manage suction waste by providing simple, safe, and complete solutions for clinical fluid disposal.
• Kit Components Component parts and accessories used in medical kits and procedural trays for healthcare delivery.
• MedXL
• Contract Manufacturing Services Contract manufacturing services for medical devices, leveraging Amsino's manufacturing capabilities to produce single-use medical products for healthcare industry customers.

Quantifiable outcome

• Over 500 million units annual capacity following MedXL acquisition
• +1 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Partners CooperativecoreGTM or Marketing Partner · 1 January 2026Three-year partnership effective January 1, 2026, granting Partners Cooperative members access to Amsino's pre-filled saline flush syringe products. The agreement includes participation in Amsino's Supply Resiliency Program, which dedicates a defined share of North American manufacturing capacity exclusively to Partners members to ensure uninterrupted product availability.
• ampiezzacoreGTM or Marketing Partner · 1 December 2025Amsino announced an agreement with ampiezza, a sourcing entity founded by Ochsner Health and supported by Vizient, effective December 1, 2025. The agreement grants contracted pricing access to Amsino's Pre-Filled Flush Syringes portfolio for ampiezza's membership base of over 90 health systems.
• Mount Sinai Health SystemcoreGTM or Marketing Partner · 13 November 2025Strategic agreement making Amsino the exclusive supplier of flush syringes to Mount Sinai Health System. The partnership includes supplying various syringe configurations to support critical medical practices across Mount Sinai's extensive network.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Smiths Medical (ICU Medical): Smiths Medical (now part of ICU Medical) operates in comparable medical device categories including IV therapy, safety devices, and hospital consumables, providing overlapping competition particularly in medication delivery and critical care devices.

Others

• McKesson: McKesson is a leading pharmaceutical and medical supply distributor that operates GPO services (including its own aggregation programs) and distributes medical devices to hospitals, making it both a potential channel partner and adjacent competitor to Amsino's GPO-led distribution model.
• Owens & Minor: Owens & Minor is a healthcare logistics and medical products company that distributes single-use medical supplies and devices to hospitals and health systems, operating with a similar GPO-anchored distribution model and serving overlapping hospital customers as Amsino.

Direct peers

• Medline Industries: Medline is a large privately held medical supply manufacturer and distributor with a comparable business model of selling single-use medical devices and consumables directly to hospitals and through GPO contracts. Its broad portfolio overlaps substantially with Amsino's product lines.
• Teleflex: Teleflex manufactures medical devices in urology, respiratory care, and surgical solutions, directly competing with Amsino's AMSure urological, respiratory therapy, and surgical/nursing product lines sold to hospital customers.
• ICU Medical: ICU Medical is a direct competitor in IV therapy and pre-filled flush syringes, with a comparable portfolio of needlefree connectors (MicroClave competes with Amsino's MicroClave), IV sets, and critical care medical devices sold to hospitals through similar GPO channels.
• Fresenius Kabi: Fresenius Kabi is a global medical device and pharmaceutical company with overlapping offerings in IV therapy, infusion systems, enteral nutrition, and sterile solutions, directly comparable to Amsino's AMSafe, AMSure enteral, and sterile water/saline portfolios.

Broad incumbents

• Cardinal Health: Cardinal Health is a major healthcare distributor and medical products manufacturer with a substantial portfolio of single-use medical devices and consumables sold to hospitals and health systems through GPO relationships comparable to Amsino's go-to-market motion.
• Baxter International: Baxter is a major medical products company with overlapping portfolios in IV therapy, sterile fluids, surgical solutions, and urology. Its global manufacturing footprint and hospital relationships make it a key competitor for Amsino's medication delivery and urological care lines.
• Becton, Dickinson and Company (BD): BD is a global incumbent in medical devices and supplies with a dominant position in flush syringes, IV therapy, urology, and surgical products. While much larger and more diversified than Amsino, BD competes directly across multiple Amsino product lines through GPO contracts.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/amsino-international-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amsino International